Paper Details

  1. Home
  2. Paper Details

Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.

Author: BakerWilliam L, CiosDeborah A, ColemanCraig I, SanderStephen D

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study looks at the challenges of managing anticoagulation in patients with atrial fibrillation (AF) and the impact of different settings on the proportion of time spent within the therapeutic range for the international normalized ratio (INR).
Paper Details　
Original Abstract of the Article :
Atrial fibrillation (AF) affects a significant proportion of the American population and increases ischemic stroke risk by 4- to 5-fold. Oral vitamin K antagonists, such as warfarin, can significantly reduce this stroke risk but can be difficult to dose and monitor. Previous research on the effects ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437339/

データ提供：米国国立医学図書館（NLM）

Warfarin Control in Atrial Fibrillation: A Meta-Analysis of US Patients

Atrial fibrillation (AF) is a common heart rhythm disorder that increases the risk of stroke. Oral vitamin K antagonists, such as warfarin, are used to reduce this risk, but they require careful monitoring and dosage adjustments. This meta-analysis examines the quality of warfarin control in AF patients in the United States, focusing on factors that might influence the effectiveness of treatment.

Warfarin Control in Atrial Fibrillation: A Need for Improvement

The meta-analysis revealed that the quality of warfarin control in AF patients in the US varied significantly across different settings. This finding highlights the importance of ensuring that patients receive appropriate monitoring and care to optimize their warfarin treatment. The researchers identified key factors that can influence the effectiveness of warfarin therapy, such as patient characteristics, treatment setting, and healthcare provider expertise. This research emphasizes the need for improvements in warfarin management to reduce the risk of stroke in AF patients.

Optimizing Warfarin Treatment for Atrial Fibrillation

The study's findings underscore the importance of implementing strategies to improve warfarin management in AF patients. This might involve improving patient education, enhancing healthcare provider training, and implementing standardized protocols for warfarin monitoring. The goal is to optimize warfarin treatment, ensuring that patients receive the right dose at the right time to minimize the risk of stroke and maximize the benefits of this important medication. This research serves as a catalyst for improvement in warfarin management for AF patients in the US.

Dr.Camel's Conclusion

This meta-analysis reveals that the quality of warfarin control in AF patients in the US is like a desert landscape – a vast expanse with areas of high and low quality. Just as a camel navigates a desert, seeking out water sources, healthcare providers must navigate the complexities of warfarin management, ensuring that patients receive the appropriate care and monitoring to optimize their treatment. This research is a reminder that continuous improvement is essential to ensure that AF patients receive the highest quality of care.

Date :
  1. Date Completed 2009-06-05
  2. Date Revised 2023-08-23
Further Info :

Pubmed ID

19326955

DOI: Digital Object Identifier

PMC10437339

Related Literature

Article Analysis
・Effects of warfarin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.